EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring Novel Drug Combinations: The Therapeutic Potential of Selanyl Derivatives for Leishmania Treatment

Andreina Henriquez-Figuereo iD, Esther Moreno iD, Carmen Sanmartin iD, Daniel Plano iD

Molecules · 2023

DOI: 10.3390/molecules28155845 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Andreina Henriquez-Figuereo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology and Chemistry, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain. Hauptthemen laut MEDLINE: Leishmaniasis, Visceral, Antiprotozoal Agents, Leishmania infantum. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Tropical Health of University of Navarra (ISTUN), Caixa Foundation, Roviralta and Ubesol, Spain.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This work describes the design, synthesis, and biological activities of new selenoester derivatives and its homologs thioesters. Thirty-two compounds were developed following an economical synthetic route, achieving small molecules, with structural characteristics similar to those present in antileishmanial drugs such as miltefosine (MIL) and paromomycin (PMN). These compounds were tested in vitro against strains of Leishmania major (L. major) and Leishmania infantum (L. infantum). The L. infantum strain (causative agent of visceral leishmaniasis) exhibited the highest sensitivity. Thus, four selanylacetic acid derivatives (A4, A5, A6 and A8) presented IC50 values below 40 µM in this strain. These derivatives also demonstrated low toxicity and high selectivity in PMA-differentiated THP-1 macrophages. The A4–A6 and A8 derivatives were evaluated in order to determine their pharmacological behavior, using drug combination studies with the reference drugs amphotericin B (AMB), MIL and PMN. Compounds A6 and A8 presented a potent synergistic interaction with MIL, which is the only oral drug available for the treatment of visceral leishmaniasis. Therefore, compounds A6 and A8 present significant potential as therapeutic candidates for the treatment of leishmaniasis based on their remarkable leishmanicidal characteristics and pharmacological synergism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmaniasis, VisceralAntiprotozoal AgentsLeishmania infantumHumansAnimalsMiceAmphotericin BParomomycinDrug CombinationsMice, Inbred BALB C

Stichwörter der Autor:innen

Leishmaniadrug-combinationselanylseleniumsynergy

Substanzen

Antiprotozoal AgentsAmphotericin BParomomycinDrug Combinations

Autor:innen und Institutionen

  • Department of Pharmaceutical Technology and Chemistry, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.
  • Institute of Tropical Health (ISTUN), University of Navarra, 31008 Pamplona, Spain.
  • Navarra Institute for Health Research (IdisNA), 31008 Pamplona, Spain.

ORCID-Profile: Andreina Henriquez-Figuereo, Esther Moreno, Carmen Sanmartin, Daniel Plano

Förderung

  • Institute of Tropical Health of University of Navarra (ISTUN)
  • Caixa Foundation
  • Roviralta and Ubesol, Spain
  • University of Navarra (ISTUN)

Zitieren

APA

Henriquez-Figuereo, A., Moreno, E., Sanmartin, C., & Plano, D. (2023). Exploring Novel Drug Combinations: The Therapeutic Potential of Selanyl Derivatives for Leishmania Treatment. Molecules. https://doi.org/10.3390/molecules28155845

Vancouver

Henriquez-Figuereo A, Moreno E, Sanmartin C, Plano D. Exploring Novel Drug Combinations: The Therapeutic Potential of Selanyl Derivatives for Leishmania Treatment. Molecules. 2023. doi:10.3390/molecules28155845

BibTeX
@article{HenriquezFiguereo2023,
  author = {Henriquez-Figuereo, Andreina and Moreno, Esther and Sanmartin, Carmen and Plano, Daniel},
  title = {Exploring Novel Drug Combinations: The Therapeutic Potential of Selanyl Derivatives for Leishmania Treatment},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28155845}
}
Kostenlos starten →